tirzepatide and pregnancy reddit What we still don't know about weight-loss drugs Hi - has anyone gotten

For the future, we can hope for more robust evidence to guide expert recommendations

Established thrombotic risk factors commonly present in semaglutide users include: Obesity (BMI 30 kg/m), which increases VTE risk 2-3 fold [13] Type 2 diabetes and insulin resistance Prolonged immobility or sedentary lifestyle History of previous blood clots Active cancer or recent cancer treatment Recent surgery, particularly orthopedic or abdominal procedures Smoking Certain medications, including estrogen-containing contraceptives or hormone replacement therapy Inherited thrombophilias (clotting disorders) Advanced age (risk increases after age 60) Pregnancy and postpartum period (note that semaglutide should be discontinued when pregnancy is recognized) Patients initiating semaglutide should undergo comprehensive baseline assessment including medical history review, with particular attention to prior thrombotic events and family history of clotting disorders

**Origin Country: China

On the other hand, it is reported that TGF1 is a possible driver of Rho-associated coiled-coil protein kinase (ROCK) (Milenkovic et al., 2019d)

ZannadFCannonCPCushmanWCBakrisGLMenonVPerezATet al